Erratum: BR.31 Trial: Adjuvant Durvalumab as the Third Contender in Resected Non–Small Cell Lung Cancer
Year: 2026
Type: erratum
Source: Journal of Clinical Oncology
DOI: 10.1200/jco-26-00221
Authors: Jordi Remon, Tina Cascone, Solange Peters
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7128201779
Cites:
Cited by:
Related to: